283 related articles for article (PubMed ID: 27342768)
1. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study.
Dodd PJ; Sismanidis C; Seddon JA
Lancet Infect Dis; 2016 Oct; 16(10):1193-1201. PubMed ID: 27342768
[TBL] [Abstract][Full Text] [Related]
2. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling.
Knight GM; McQuaid CF; Dodd PJ; Houben RMGJ
Lancet Infect Dis; 2019 Aug; 19(8):903-912. PubMed ID: 31281059
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.
Ismail NA; Mvusi L; Nanoo A; Dreyer A; Omar SV; Babatunde S; Molebatsi T; van der Walt M; Adelekan A; Deyde V; Ihekweazu C; Madhi SA
Lancet Infect Dis; 2018 Jul; 18(7):779-787. PubMed ID: 29685458
[TBL] [Abstract][Full Text] [Related]
4. Global and Regional Burden of Isoniazid-Resistant Tuberculosis.
Yuen CM; Jenkins HE; Rodriguez CA; Keshavjee S; Becerra MC
Pediatrics; 2015 Jul; 136(1):e50-9. PubMed ID: 26034243
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis.
Aziz MA; Wright A; Laszlo A; De Muynck A; Portaels F; Van Deun A; Wells C; Nunn P; Blanc L; Raviglione M;
Lancet; 2006 Dec; 368(9553):2142-54. PubMed ID: 17174706
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
[TBL] [Abstract][Full Text] [Related]
7. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
Khurana P; Saigal K; Ghosh A
Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
[TBL] [Abstract][Full Text] [Related]
9. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
Houben RM; Dodd PJ
PLoS Med; 2016 Oct; 13(10):e1002152. PubMed ID: 27780211
[TBL] [Abstract][Full Text] [Related]
10. Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia.
Elhassan MM; Hemeg HA; Elmekki MA; Turkistani KA; Abdul-Aziz AA
Infect Disord Drug Targets; 2017; 17(1):14-23. PubMed ID: 27848902
[TBL] [Abstract][Full Text] [Related]
11. [Multidrug-resistant tuberculosis].
Alcaide F; Santín M
Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():54-60. PubMed ID: 19100168
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
13. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N
PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
Al-Mutairi NM; Ahmad S; Mokaddas EM
Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
[TBL] [Abstract][Full Text] [Related]
16. Management of multidrug resistant tuberculosis.
Daley CL; Caminero JA
Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
[TBL] [Abstract][Full Text] [Related]
17. National survey of drug-resistant tuberculosis in China.
Zhao Y; Xu S; Wang L; Chin DP; Wang S; Jiang G; Xia H; Zhou Y; Li Q; Ou X; Pang Y; Song Y; Zhao B; Zhang H; He G; Guo J; Wang Y
N Engl J Med; 2012 Jun; 366(23):2161-70. PubMed ID: 22670902
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
[TBL] [Abstract][Full Text] [Related]
19. Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen.
Lempens P; Decroo T; Aung KJM; Hossain MA; Rigouts L; Meehan CJ; Van Deun A; de Jong BC
Int J Infect Dis; 2020 Nov; 100():357-365. PubMed ID: 32829049
[TBL] [Abstract][Full Text] [Related]
20. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
Chang KC; Yew WW
Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
